ARGINASE INHIBITORS AND METHODS OF USE

Described herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds of Formula (I) act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.

Saved in:
Bibliographic Details
Main Authors Lu, Min, Mitcheltree, Matthew J, Gathiaka, Symon, Cumming, Jared N, Li, Derun, Fischer, Christian, Palani, Anandan, Zhang, Hongjun, Achab, Abdelghani Abe, Sloman, David L, Lesburg, Charles A, Palte, Rachel L
Format Patent
LanguageEnglish
Published 03.06.2021
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:Described herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds of Formula (I) act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related diseases.
Bibliography:Application Number: US201916973623